Lack of CD117 and rare bcl-2 expression in stomach cancer by immunohistochemistry. An immunohistochemical study with review of the literature

Table 2 Details of demographic, microscopic, pathologic and immunohistochemical findings in the study cases

Ser. No.	Sex	Age	Year of Operation	Location	Cell Type	Grade	Stage
1	F	50	1999	A	D	-	IIIB
2	F	48	1999	DI	D	-	IV
3	M	70	1999	B	D	-	IIIA
4	F	65	1999	A	I	PD	IIIA
5	M	58	1999	A	D	-	IIIA
6	M	59	1999	DI	D	-	IIIA
7	M	75	1999	B	I	MD	IIIA
8	M	28	2000	A	D	-	IIIB
9	M	65	2000	A	D	-	II
10	F	65	2000	A	I	WD	IIIB
11	F	54	2001	A	D	-	IIIA
12	M	70	2001	B	I	PD	IIIA
13	M	70	2001	C	D		IV
14	M	45	2001	C, B	I	PD	IIIB
15	M	60	2001	A	I	MD	II
16	M	51	2001	A	I	MD	IIIB
17	F	67	2001	B	D	-	IIIB
18	F	67	2002	C	D	-	IIIB
19	M	39	2002	C	I	WD	IIIA
20	F	79	2002	B	I	MD	IIIA
21	F	44	2002	DI	D	-	IIIA
22	M	63	2002	A	I	WD	IB
23	M	48	2002	A	I	PD	IIIB
24	M	52	2002	DI	D	-	IIIB
25	M	68	2002	A	I	WD	II
26	M	70	2002	A	I	WD	IIIA
27	M	88	2002	A	I	PD	IIIA
28	F	30	2003	C	I	MD	IIIA
29	M	53	2003	C	I	WD	IB
30	F	53	2003	C	I	MD	IIIB
31	F	60	2003	-	I	PD	IIIB
32	F	48	2003	A	D		IIIB
33	M	42	2003	A	Mucinous	WD	IIIA
34	M	65	2003	B	D	-	IIIB
35	M	45	2003	DI	D	-	IIIA
36	M	23	2003	GEJ	I	WD	IIIA
37	M	58	2003	A	D	-	IIIB
38	F	35	2003	A	I	PD	IIIB

Abbreviations: M: male; F: female; A: antral; B: body; C: cardia; DI: diffuse infiltrative; GEJ: gastro-esophageal junction; D: diffuse type; I: intestinal type; PD: poorly differentiated; MD: moderately differentiated; WD: well differentiated.